NEW YORK (GenomeWeb News) – MicroRNA test development firm Circulomics said today it has been awarded two National Institutes of Health grants totaling $800,000 to develop its technology.

The Small Business Innovative Research Phase I awards will go toward the development of Circulomics' Ligo-miR microRNA assay technology and PicoSep single-molecule analysis platform.

The awards were made through NIH's SHIFT initiative to support the commercialization of academic discoveries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.